Novocure Ltd (NVCR) Financials

NVCR Assets vs Liabilities
DateAssetsLiabilities
Sept. 30, 2026 828.7 million 478.1 million
June 30, 2026 795.2 million 457.1 million
March 31, 2026 787.9 million 457.2 million
Dec. 31, 2025 804.3 million 463.9 million

NVCR Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Sept. 30, 2026 15.7 million 17.5 million
June 30, 2026 5.5 million 17.0 million
March 31, 2026 -18.7 million 63.0 million
Dec. 31, 2025 -22.9 million 19.8 million

NVCR Net Income

No data available :(

NVCR Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Sept. 30, 2026 463.5 million 171.3 million 35.2 million
June 30, 2026 440.6 million 195.9 million 37.5 million
March 31, 2026 441.8 million 195.5 million 39.5 million
Dec. 31, 2025 457.5 million 236.7 million 41.6 million

NVCR Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Sept. 30, 2026 116.8 million
June 30, 2026 116.0 million
March 31, 2026 114.1 million
Dec. 31, 2025 111.5 million

NVCR Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Sept. 30, 2026 6.9 million 58.1 million 96.9 million 53.3 million
June 30, 2026 6.9 million 51.4 million 101.6 million 61.7 million
March 31, 2026 5.2 million 58.3 million 144.2 million 58.4 million
Dec. 31, 2025 4.9 million 60.9 million 111.7 million 68.7 million

NVCR Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Sept. 30, 2026 193.4 million 44.5 million
June 30, 2026 183.6 million 41.1 million
March 31, 2026 174.1 million 38.9 million
Dec. 31, 2025 174.4 million 42.2 million

NVCR

Price: $14.82

52 week price:
9.82
21.45

Earnings Per Share: -1.06 USD

Exchange: NMS

Sector: Healthcare

Industry: Medical Devices

Country: Jersey

Volume: 542600

Ebitda: -3.9 million

Market Capitalization: 1.5 billion

Links: